drugset / Trial / NCT06091904
Effects of Sufentanil on the Intraoperative Hemodynamics
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
Timeline
- Start
- 2023-11-24
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Remifentanil | Small molecule | 0.5 ng/ml | — |
| Comparator | Remifentanil | Small molecule | 5 ng/ml | — |
| Subject | Sufentanil | Other / unclassified | 0.05 ng/ml | — |
| Subject | Sufentanil | Other / unclassified | 0.5 ng/ml | — |
Indications
No indication recorded.